Women’s HealthX, the only event set to change the future of women’s health through data, science, and evidence-based innovation, launches in Boston this December
Women’s HealthX (WoHX) is the number one event in women’s health, unifying the full lifecycle of female healthcare through data, science, and evidence-based innovation to close the sex difference data gap and drive better clinical outcomes for women worldwide.
On December 3–4, 2026 in Boston, WoHX will bring together 750 global leaders from pharma and biotech, hospitals and health systems, health insurers, employers, investors, startups, and government, all actively seeking proven technologies, data, and partners to advance women’s health care, research, and outcomes across the life course.
Unlike any other event, WoHX goes beyond discussion to focus on implementation of representative data sets to drive meaningful change. The exhibition directly addresses the conditions that affect women differently and disproportionately, across every stage of life.
Attendees will gain clear insight into which areas are overhyped versus underfunded, where the biggest evidence gaps remain, and how data, science, and evidence can drive measurable change in policy, reimbursement, product development, and clinical practice.
Julie Rios, Division Director, Reproductive Endocrinology & Infertility at UPMC, shared why she is looking forward to attending:
“I’m looking forward to connecting with innovators across women’s health to explore new technologies, collaborations, and care models that can help us solve our most complex reproductive health cases and improve outcomes for patients who currently have limited options.”
Taking place in Boston, the global hub for healthcare innovation, research, and medical institutions, whose collaborative ecosystem aligns perfectly with WoHX’s mission to accelerate the adoption of clinical solutions, and improve outcomes for women worldwide.
Across seven dedicated stages spanning Evidence, Data & Innovation, Fertility & Reproductive Health, Menopause & Healthy Aging, Maternity & Maternal Care, Sexual Health & Wellness, Cognitive Health & Wellness, and Chronic Disease Management, attendees will benefit from:
- 100+ hours of free education from 150+ expert speakers
- Direct access to senior decision-makers and key industry leaders
- Tailored one-to-one meetings with solution providers across medical devices, CROs, and analytics software
- Hands-on exploration of AI-powered tools, digital therapeutics, wearables, telehealth, and integrated care models via the interactive HealthXpo floor, featuring live demonstrations and hands-on clinical showcases
- The Women’s Health Startup Zone, connecting founders directly with investors
- The Career Zone, linking attendees with postgraduate programs, universities, and research centres, alongside masterclasses in AI literacy, data analytics, and research innovation
Early confirmed speakers include:
- Michael Annichine, CEO, Magee-Womens Research Institute and Foundation
- David Friend, Chief Science Officer, Daré Bioscience
- Emily Lau, Director, Women’s Heart Health Program, Brigham and Women’s Hospital
- Carolee Lee, CEO & Founder, WHAM
- Suneela Vegunta, Vice Chair, Women’s Health Research Division, Mayo Clinic
- Barb DePree, Director of Women’s Health, Holland Hospital
- Jodi Neuhauser, Founder & CEO, In Women’s Health
- Julie Rios, Division Director, Reproductive Endocrinology & Infertility, UPMC
- Kesha O’Reilly, Global Director, Medical Affairs HIV Franchise, Gilead Sciences
- Katie Baca-Motes, CEO GSD, Health Research
- Catherine Monk, Founding Director, Center for the Transition to Parenthood
- Mitzi Krockover, CEO & Founder, WomanCentered
Further announcements, including speaker confirmations and agenda highlights, will be released in the coming months.
Because we believe in healthcare equity, attendance is free for any medical officers and leaders within hospitals and healthcare systems, pharma, biotech, corporate enterprises and government officials.
